DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Orencia (Abatacept) - Current Clinical Trials

 
 



Orencia Related Clinical Trials

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA) [Completed]

Phase IIIB Subcutaneous Abatacept Monotherapy Study [Completed]

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) [Recruiting]

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis [Recruiting]

Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study [Withdrawn]

Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday [Completed]

Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background [Recruiting]

A Study of Abatacept in Patients With Active Crohn's Disease [Terminated]

Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study [Active, not recruiting]

TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Recruiting]

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers [Completed]

A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept [Completed]

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Completed]

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone [Completed]

Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris [Recruiting]

Efficacy and Safety of Abatacept in Patients With Primary Sj�gren's Syndrome [Recruiting]

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg [Completed]

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis [Terminated]

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis [Not yet recruiting]

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) [Recruiting]

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata [Withdrawn]

A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) [Recruiting]

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Active, not recruiting]

Long-term Experience With Abatacept SC in Routine Clinical Practice [Recruiting]

Long Term Experience With Abatacept in Routine Clinical Practice [Active, not recruiting]

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Completed]

Abatacept Reduced Intensity for Non-Malignant Diseases [Recruiting]

Abatacept for SLE Arthritis (IM101-330) [Not yet recruiting]

Abatacept in the Treatment of Uveitis [Recruiting]

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis [Completed]

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients [Completed]

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis [Completed]

Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy [Active, not recruiting]

Abatacept as GVHD Prophylaxis Phase 2 [Recruiting]

Real-world Clinical Efficacy of Abatacept in the T3 Data Registry [Active, not recruiting]

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Completed]

Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant [Recruiting]

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb [Completed]

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis [Completed]

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis [Completed]

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata [Active, not recruiting]

Korean Post-marketing Surveillance for Orencia [Recruiting]

Methotrexate - Inadequate Response Device Sub-Study [Completed]

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis [Active, not recruiting]

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis [Completed]

Abatacept Post-marketing Clinical Study in Japan [Recruiting]

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo [Recruiting]

Safety Study of Abatacept to Treat Refractory Sarcoidosis [Terminated]

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches [Recruiting]

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Completed]

Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept [Not yet recruiting]

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis [Recruiting]

Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept [Withdrawn]

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography [Completed]

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan [Recruiting]

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 [Recruiting]

A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome [Recruiting]

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting [Active, not recruiting]

Abatacept Versus Adalimumab Head-to-Head [Completed]

Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients [Completed]

A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate [Completed]

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis [Terminated]

A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) [Completed]

Study on the Safety of Abatacept in Relapsing Polychondritis [Completed]

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients [Completed]

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis [Completed]

Islet Transplantation Using Abatacept [Completed]

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics [Completed]

Abatacept Treatment in Polymyositis and Dermatomyositis [Recruiting]

Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis [Withdrawn]

Effects of Abatacept in Patients With Early Rheumatoid Arthritis [Not yet recruiting]

Abatacept in ANCA Associated Vasculitis [Terminated]

Predictors of Adherence to Orencia [Completed]

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis [Completed]

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy [Completed]

Remission and Joint Damage Progression in Early Rheumatoid Arthritis [Completed]

Phase IIIB Switching From Intravenous to Subcutaneous Study [Completed]

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan [Recruiting]

Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage [Completed]

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis [Recruiting]

Post-marketing Study Assessing the Long-Term Safety of Abatacept [Active, not recruiting]

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Completed]

The Study of Abatacept in Combination With Etanercept [Completed]

Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation [Terminated]

Dose Escalation With Remicade and Orencia [Completed]

Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity [Recruiting]

Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) [Active, not recruiting]

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015